Comparing COVID-19 vaccines

A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...
Forbes

What To Know About The New Updated COVID Vaccines For 2025-2026

The FDA recently approved new COVID-19 vaccines for Americans, but due to certain restrictions, there has been mounting confusion on what they are, how much protection they’ll offer and whether ...

FDA claims Covid shots killed 10 children and vows new vaccine rules

Vaccine experts said the memo was irresponsible and omits key details about how officials arrived at the conclusion.
Seeking Alpha

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Nuvaxovid™ is the only protein-based, non-mRNA COVID-19 vaccine available in the U.S. for the 2025-2026 vaccination season "With today's approval, we will work with our partner Sanofi to provide ...
Benzinga.com

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential

Shah Capital is reportedly pressing Novavax Inc. (NASDAQ:NVAX) to consider a sale of the biotech firm, citing continued struggles in the rollout of its COVID-19 vaccine. • NVAX stock is showing ...
abc7NY

COVID News: Novavax says its vaccine could win over skeptics

NEW YORK (WABC) -- The biotechnology company Novavax plans to submit complete data to the US Food and Drug Administration soon for possible emergency use authorization of its coronavirus vaccine ...

Moderna stock falls after FDA vows to impose new vaccine requirements

Vinay Prasad, a top FDA official, blamed COVID shots for playing a role in the deaths of 10 children in a memo he sent to ...
WTKR

Biden administration orders millions of Novavax COVID-19 vaccine doses

The Biden administration announced Monday that it would purchase 3.2 million doses of the Novavax COVID-19 vaccine. It will be offered at no cost to states and federal partners. “We remain ...
Reuters

Novavax lays out specific minority targets for U.S. COVID-19 vaccine trial

CHICAGO, Oct 30 (Reuters) - Novavax Inc (NVAX.O), opens new tab on Friday outlined specific diversity targets for its large-scale COVID-19 vaccine study expected to begin in the United States ...

Moderna falls after FDA vows to impose new vaccine requirements

Moderna Inc. fell in premarket trading Monday after the Food and Drug Administration said in a memo late last week it would place new restrictions on which vaccines hit the market.